Acris Antibodies Logo

Antibodies and related products for scientific research: primary antibodies: 71.006, secondary ab: 1.096, proteins: 20.577, kits: 265, other products: 1.054

<b>Figure 1.</b> Conjugation pathways for ubiquitin and ubiquitin-like modifiers (UBLs). Most modifiers mature by proteolytic processing from inactive precursors (a; amino acid).
Arrowheads point to the cleavage sites. Ubiquitin is expressed either as polyubiquitin or as a fusion with ribosomal proteins.
Conjugation requires activating (E1) and conjugating (E2) enzymes that form thiolesters (S) with the modifiers. Modification of cullins
by RUB involves SCF(SKP1/cullin-1/F-box protein) /CBC(cullin-2/elongin B/elongin C)-like E3 enzymes that are also involved in ubiquitination. In contrast to ubiquitin, the UBLs do not seem to form multi-UBL chains. UCRP(ISG15) resembles two ubiquitin moieties linked head-to-tail. Whether HUB1 functions as a modifier
is currently unclear. APG12 and URM1 are distinct from the other modifiers because they are unrelated in sequence to ubiquitin.
Data contributed by S.Jentsch, see references above.

 

Zoom Out
Zoom In

R1510  Cullin-2 (CUL-2) (C-term.) antibody

see related secondary antibodies
see all 8 Cullin-2 products
0.1 ml / US$ 465
NOVUS BIOLOGICALS
PO Box 802 Littleton, CO 80160, USA
E-Mail: novus@novus-biologicals.com
Homepage: http://www.novus-biologicals.com

Quick Overview

Rabbit anti Cullin-2 (CUL-2) (C-term.) -

Synonyms

Cullin 2 CUL2

Product review
Please read our product review about Cullin-2 (CUL-2) (C-term.): Antibodies to Cullin Protein Family.

Product Description

Rabbit anti Cullin-2 (CUL-2) (C-term.) -, Presentation: Serum. Product is tested for Enzyme Immunoassay ( E ), Immunoprecipitation ( IP ), Westernblot / Immunoblot ( WB )

Properties

ApplicationsEnzyme Immunoassay ( E ), Immunoprecipitation ( IP ), Westernblot / Immunoblot ( WB )
ReactivityHuman ( Hu )
PresentationSerum
HostRabbit
Catalog NumberR1510
Quantity0.1 ml
PriceUS$ 465
DeliveryWorldwide
ManufacturerAcris Antibodies GmbH
Datasheetview PDF-Download
R1510.pdf

Datasheet Extract

Polyclonal Antibody to Human Cul2 //(C-terminal specific)
Alternate namesCullin 2
Concentration85.0 mg/ml (by Refractometry)
BackgroundCullins assemble a potentially large number of ubiquitin ligases by binding to the RING protein ROC1 to catalyse polyubiquitination, as well as binding to various specificity factors to recruit substrates. Cullin 2 is an essential component of the SCF (SKP1-CUL1-F-box protein) E3 ubiquitin ligase complex, which mediates the ubiquitination of proteins involved in cell cycle progression, signal transduction and transcription. In the SCF complex, cul2 serves as a rigid scaffold that organizes the SKP1-F-box protein and RBX1 subunits. Cul2 may also contribute to catalysis through positioning of the substrate and the ubiquitin-conjugating enzyme. Cul2 is part of the SCF complex consisting of CUL1, RBX1, SKP1 and SKP2, where it interacts directly with SKP1, SKP2 and RBX1. Cul2 also interacts with RNF7 and is part of a complex with TIP120A/CAND1 and RBX1. The unneddylated form interacts with TIP120A/CAND1 and the interaction negatively regulates the association with SKP1 in the SCF complex.
ImmunogenSynthetic peptide corresponding to amino acids 733-745 of Human Cul2 (C-terminus) coupled to KLH.
AA Sequence: Human Cullin 2 (745 aa 86.9 kDa):
1 mslkprvvdf detwnklltt ikavvmleyv eratwndrfs diyalcvayp eplgerlyte
61 tkiflenhvr hlhkrvlese eqvlvmyhry weeyskgady mdclyrylnt qfikknklte
121 adlqygyggv dmneplmeig elaldmwrkl mveplqaili rmllreiknd rggedpnqkv
181 ihgvinsfvh veqykkkfpl kfyqeifesp fltetgeyyk qeasnllqes ncsqymekvl
241 grlkdeeirc rkylhpssyt kvihecqqrm vadhlqflha echniirqek kndmanmyvl
301 lravstglph miqelqnhih deglratsnl tqenmptlfv esvlevhgkf vqlintvlng
361 dqhfmsaldk altsvvnyre pksvckapel lakycdnllk ksakgmtene vedrltsfit
421 vfkyiddkdv fqkfyarmla krlihglsms mdseeamink lkqacgyeft sklhrmytdm
481 svsadlnnkf nnfiknqdtv idlgisfqiy vlqagawplt qapsstfaip qeleksvqmf
541 elfysqhfsg rkltwlhylc tgevkmnylg kpyvamvtty qmavllafnn setvsykelq
601 dstqmnekel tktikslldv kminhdseke didaessfsl nmnfsskrtk fkittsmqkd
661 tpqemeqtrs avdedrkmyl qaaivrimka rkvlrhnali qevisqsrar fnpsismikk
721 cievlidkqy iersqasade ysyva

Format
State: Liquid (sterile filtered) containing 0.01% (w/v) Sodium Azide as preservative.
Purification: Delipidation and defibrination.
Purity: and
ApplicationsWestern blot: This antibody reacts with human Cul2 (1/500-1/1,000; An 86.9 kDa band corresponding to human Cul2 is detected). Most cell lines expressing Cul2 can be used as a positive control).
Immunoprecipitation: The antibody immunoprecipitates in vitro translated product and protein from cell lysates (using HeLa or NIH-3T3).
ELISA (1/2,000-1/10,000).
Description
AASequence: Human Cullin 2 (745 aa 86.9 kDa)

1 mslkprvvdf detwnklltt ikavvmleyv eratwndrfs diyalcvayp eplgerlyte
61 tkiflenhvr hlhkrvlese eqvlvmyhry weeyskgady mdclyrylnt qfikknklte
121 adlqygyggv dmneplmeig elaldmwrkl mveplqaili rmllreiknd rggedpnqkv
181 ihgvinsfvh veqykkkfpl kfyqeifesp fltetgeyyk qeasnllqes ncsqymekvl
241 grlkdeeirc rkylhpssyt kvihecqqrm vadhlqflha echniirqek kndmanmyvl
301 lravstglph miqelqnhih deglratsnl tqenmptlfv esvlevhgkf vqlintvlng
361 dqhfmsaldk altsvvnyre pksvckapel lakycdnllk ksakgmtene vedrltsfit
421 vfkyiddkdv fqkfyarmla krlihglsms mdseeamink lkqacgyeft sklhrmytdm
481 svsadlnnkf nnfiknqdtv idlgisfqiy vlqagawplt qapsstfaip qeleksvqmf
541 elfysqhfsg rkltwlhylc tgevkmnylg kpyvamvtty qmavllafnn setvsykelq
601 dstqmnekel tktikslldv kminhdseke didaessfsl nmnfsskrtk fkittsmqkd
661 tpqemeqtrs avdedrkmyl qaaivrimka rkvlrhnali qevisqsrar fnpsismikk
721 cievlidkqy iersqasade ysyva

Specific
SpecificityThis product is monospecific antiserum processed by delipidation and defibrination followed by sterile filtration.
This product reacts with human Cullin 2.
Cross reactivity with Cul2 from other sources has not been determined.
StorageStore vial at -20°C prior to opening. Centrifuge product if not completely clear after standing at room temperature. Dilute only prior to immediate use.
For extended storage aliquot contents and freeze at -20°C or below.
Avoid cycles of freezing and thawing.
Shelf life: one year from despatch.
References1. Feng, H., Zhong, W., Punkosdy, G., Gu, S., Zhou, L., Seabolt,. E.K. and Kipreos, E.T. (1999) CUL-2 is required for the G1-to S-phase transition and mitotic chromosome condensation in Caenorhabditis elegans. Nat Cell Bio 1, 486-492.
2. Kipreos,E.T., Lander,L.E., Wing,J.P., He,W.W. and Hedgecock,E.M. (1996) cul-1 is required for cell cycle exit in C. elegans and identifies a novel gene family. Cell 85 (6), 829-839.
3. Michel,J.J. and Xiong,Y. (1998) Human CUL-1, but not other cullin family members, selectively interacts with SKP1 to form a complex with SKP2 and cyclin A. Cell Growth Differ. 9 (6), 435-449.
4. Ohta,T., Michel,J.J., Schottelius,A.J. and Xiong,Y. (1999) ROC1, a homolog of APC11, represents a family of cullin partners with an associated ubiquitin ligase activity. Mol. Cell 3 (4), 535-541.
5. Mathias, N., Johnson, S.L., Winey, M., Adams, A.E., Goetsch, L., Pringle, J.R., Byers, B., Goebl, M.G. (1996) Cdc53p acts in concert with Cdc4p and Cdc34p to control the G1-to-S-phase transition and identifies a conserved family of proteins. Mol Cell Biol 16:12, 6634-6643.
6. Kamura,T., Sato,S., Iwai,K., Czyzyk-Krzeska,M., Conaway,R.C. and Conaway,J.W. (2000) Activation of HIF1alpha ubiquitination by a reconstituted von Hippel-Lindau (VHL) tumor suppressor complex. Proc. Natl. Acad. Sci. U.S.A. 97 (19), 10430-10435.
7. Wada,H., Yeh,E.T. and Kamitani,T. (1999) Identification of NEDD8-conjugation site in human cullin-2. Biochem. Biophys. Res. Commun. 257 (1), 100-105.
8. Pause,A., Lee,S., Worrell,R.A., Chen,D.Y., Burgess,W.H., Linehan,W.M. and Klausner,R.D. (1997) The von Hippel-Lindau tumor-suppressor gene product forms a stable complex with human CUL-2, a member of the Cdc53 family of proteins. Proc. Natl. Acad. Sci. U.S.A. 94 (6), 2156-2161.
9.Jentsch S, Pyrowolakis G. (2000) Ubiquitin and its kin: how close are the family ties. Trends Cell Biol. 10(8):335-42
PicturesFigure 1. Conjugation pathways for ubiquitin and ubiquitin-like modifiers (UBLs). Most modifiers mature by proteolytic processing from inactive precursors (a; amino acid).
Arrowheads point to the cleavage sites. Ubiquitin is expressed either as polyubiquitin or as a fusion with ribosomal proteins.
Conjugation requires activating (E1) and conjugating (E2) enzymes that form thiolesters (S) with the modifiers. Modification of cullins
by RUB involves SCF(SKP1/cullin-1/F-box protein) /CBC(cullin-2/elongin B/elongin C)-like E3 enzymes that are also involved in ubiquitination. In contrast to ubiquitin, the UBLs do not seem to form multi-UBL chains. UCRP(ISG15) resembles two ubiquitin moieties linked head-to-tail. Whether HUB1 functions as a modifier
is currently unclear. APG12 and URM1 are distinct from the other modifiers because they are unrelated in sequence to ubiquitin.
Data contributed by S.Jentsch, see references above.

12 Secondary Antibodies

Catalog No.Name / HostPresentationReactivity 
R1364B Rabbit IgG (H&L)  
  Goat Biotin   2 mg / US$ 295
   
R1364F Rabbit IgG (H&L)  
  Goat FITC   2 mg / US$ 285
   
R1364T Rabbit IgG (H&L)  
  Goat TRITC   2 mg / US$ 285
   
R1364TR Rabbit IgG (H&L)  
  Goat Texas Red   2 mg / US$ 295
   
R1364HRP Rabbit IgG (H&L)  
  Goat HRP   2 mg / US$ 295
   
R1364AP Rabbit IgG (H&L)  
  Goat AP   1 mg / US$ 325
   
R1458C2 Rabbit IgG (H&L) multi-species ads.  
  Goat Cy2   1 mg / US$ 445
   
R1458C3 Rabbit IgG (H&L) multi-species ads.  
  Goat Cy3   1 mg / US$ 445
   
R1458C35 Rabbit IgG (H&L) multi-species ads.  
  Goat Cy3.5   1 mg / US$ 445
   
R1458C5 Rabbit IgG (H&L) multi-species ads.  
  Goat Cy5   1 mg / US$ 445
   
R1458C55 Rabbit IgG (H&L) multi-species ads.  
  Goat Cy5.5   1 mg / US$ 445
   
R1427R Rabbit IgG (H&L) F(ab')2 Fragment multi-species ads.  
  Donkey PE   1 ml / US$ 455
   

Click here to see all secondary antibodies for 'R1510 Cullin-2 (CUL-2) (C-term.)'.